We have previously demonstrated the capacity of the small molecule MEK inhibitor (AZD6244) to decrease ERK1/2 phosphorylation in uveal melanoma cell lines at low nanomolar concentrations [20]. This evidence concerns the gene MAPK3 and uveal melanoma.